Updated

Scientists developed a nanoparticle therapy that delivers follistatin mRNA directly to tumors, reducing lung tumors in mice while also combating cachexia, the severe muscle wasting that often accompanies cancer. Researchers say the dual-action approach could eventually offer a way to fight both the disease and one of its deadliest complications.